Curcumin (Turmeric Extract)

Curcumin is the primary bioactive polyphenol in turmeric (Curcuma longa). It has been extensively studied for its anti-inflammatory and antioxidant properties, with the most consistent clinical evidence for joint pain relief in osteoarthritis and as adjunctive support for mood disorders.

The Bioavailability Problem

A critical limitation of standard curcumin supplements is poor oral bioavailability: at a dose of 2 g taken alone, serum levels are undetectable or negligible due to poor absorption, rapid metabolism, and fast elimination. The most established solution is co-administration with piperine (black pepper extract, typically 20 mg), which increases curcumin bioavailability by up to 2,000% by inhibiting its intestinal and hepatic metabolism. Other enhanced formulations include Meriva® (phytosome complex) and BCM-95®. Any claimed benefit from curcumin is essentially contingent on using a bioavailability-enhanced form.

Joint Pain and Osteoarthritis

The strongest clinical evidence is for knee osteoarthritis (OA). A 2024–2025 systematic review and meta-analysis of RCTs found that curcumin preparations significantly reduced WOMAC pain and stiffness scores. Multiple trials found curcumin non-inferior to NSAIDs such as ibuprofen, with far fewer gastrointestinal adverse events. A 367-patient multicentre study comparing Curcuma domestica extract to ibuprofen found equivalent pain relief with the NSAID group experiencing significantly more GI side effects.

Mood and Depression

Curcumin modulates neuroinflammatory pathways central to depression: it inhibits NF-κB and downregulates IL-6 and TNF-α , cytokines elevated in people with treatment-resistant depression. Canadian CANMAT guidelines provisionally recommend 500–1,000 mg/day as adjunctive therapy for mild-to-moderate major depressive disorder. A clinical trial with 111 participants found that adding 1,000 mg curcumin (with piperine) to antidepressant treatment produced significantly greater reductions in HAM-D and BDI-II depression scores compared to antidepressant alone.

Anti-inflammatory Mechanism

Curcumin inhibits IL-1β, TNF-α, IL-6, IL-8, PGE2, and COX-2 , overlapping with the mechanism of NSAIDs but via a distinct pathway. It also increases endogenous antioxidant enzymes including superoxide dismutase (SOD) and reduces systemic oxidative stress markers.

Cancer Prevention {#cancer-prevention}

A comprehensive 2009 review (PMID 19838007) , “Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?” , documented that curcumin disrupts all three phases of carcinogenesis: initiation (preventing DNA damage by carcinogens), promotion (suppressing inflammatory signals that sustain pre-cancerous cells), and progression (inhibiting tumor growth, angiogenesis, and metastasis). Mechanisms identified include NF-κB suppression, downregulation of growth factors (EGF, VEGF), induction of apoptosis via caspase-3 and caspase-9 activation, and HDAC inhibition affecting epigenetic cancer gene expression. A key property is selectivity: in multiple models, curcumin preferentially induces apoptosis in malignant cells while leaving normal cells largely unaffected , a quality rarely seen in synthetic anti-cancer compounds. Colorectal, breast, prostate, lung, and pancreatic cancers have all been studied. Several Phase I/II clinical trials have examined curcumin in colorectal cancer, with encouraging results in reducing pre-cancerous polyp recurrence, though large confirmatory RCTs are lacking. The bioavailability problem (see below) is a major barrier to clinical translation.

Dosing

Evidence-based dose: 500–1,500 mg/day of a bioavailability-enhanced formulation. Standard curcumin without piperine or other absorption enhancers is likely ineffective.

Anti Inflammatory {#anti-inflammatory}

Inhibits pro-inflammatory cytokines (IL-6, TNF-α, COX-2). The evidence and practical framing for this claim are covered in the page narrative above.

Joint Pain Relief {#joint-pain-relief}

Reduces joint pain in osteoarthritis; comparable to NSAIDs in trials. The evidence and practical framing for this claim are covered in the page narrative above.

Mood And Depression {#mood-and-depression}

Reduces depressive symptoms as adjunctive therapy. The evidence and practical framing for this claim are covered in the page narrative above.

Antioxidant {#antioxidant}

Reduces oxidative stress markers and increases antioxidant enzyme activity. The evidence and practical framing for this claim are covered in the page narrative above.